BIODESIX INC
Company Information
Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
Mailing Address 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
Phone 303-417-0500
Fiscal Year End 1231
EIN 203986492
Financial Overview
FY2024 FY
$49.09M
Revenue
-$42.93M
Net Income
$99.10M
Total Assets
$20.88M
Stockholders' Equity
$-0.33
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 27, 2026 | View on SEC |
| 4 Insider stock transaction report | January 27, 2026 | View on SEC |
| 4 Insider stock transaction report | January 26, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 26, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 23, 2026 | View on SEC |
Insider Trading
STRONG BUY 6 insiders
13 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.